Production (Stage)
Thermo Fisher Scientific Inc.
TMO
$393.66
-$6.82-1.70%
NYSE
| 03/29/2025 | 12/31/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.65% | 12.27% | 5.37% | 16.49% | -18.53% |
| Total Depreciation and Amortization | -5.62% | 1.77% | -7.21% | -5.38% | -0.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -153.78% | 152.19% | -40.74% | -28.57% | 73.13% |
| Change in Net Operating Assets | -339.90% | 1,880.00% | 113.89% | 72.55% | -145.68% |
| Cash from Operations | -78.02% | 51.89% | 10.51% | 56.67% | -66.40% |
| Capital Expenditure | 24.58% | -76.47% | 9.63% | 13.26% | 14.32% |
| Sale of Property, Plant, and Equipment | -29.41% | -15.00% | 25.00% | 300.00% | -63.64% |
| Cash Acquisitions | -- | 100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -136.65% | 348.97% | -706.25% | 101.90% | -9,472.22% |
| Cash from Investing | -2,735.00% | 100.56% | -1,314.23% | 87.54% | -439.89% |
| Total Debt Issued | -- | -- | 100.00% | -100.08% | -51.33% |
| Total Debt Repaid | 66.48% | -125.84% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -100.00% | -- | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00% | 0.67% | -0.67% | -10.37% | 0.74% |
| Other Financing Activities | 364.71% | -125.37% | 91.43% | -67.89% | 678.57% |
| Cash from Financing | 97.22% | -208.07% | -934.78% | 93.68% | -27.52% |
| Foreign Exchange rate Adjustments | 113.55% | -256.00% | 1,266.67% | -168.18% | 120.00% |
| Miscellaneous Cash Flow Adjustments | 200.00% | -- | -100.00% | -- | -- |
| Net Change in Cash | 120.95% | 74.04% | -253.80% | 161.21% | -233.64% |